SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.

Yi, Seonju; Choe, Young June; Kim, Jia; Kim, Yoo-Yeon; Kim, Ryu Kyung; Jang, Eun Jung; Lim, Do Sang; Byeon, Hye Ryeon; Lee, Sangwon; Park, Eonjoo; Kim, Seung-Jin; Park, Young-Joon

Yi, Seonju; Choe, Young June; Kim, Jia; Kim, Yoo-Yeon; Kim, Ryu Kyung; Jang, Eun Jung; Lim, Do Sang; Byeon, Hye Ryeon; Lee, Sangwon; Park, Eonjoo; Kim, Seung-Jin; Park, Young-Joon.

Emerg Infect Dis ; 28(3): 753-756, 2022 03.

Article em En | MEDLINE | ID: mdl-35202529

Assuntos

Vacinas contra COVID-19; COVID-19; COVID-19/epidemiologia; COVID-19/prevenção & controle; Humanos; República da Coreia/epidemiologia; Estudos Retrospectivos; SARS-CoV-2

Palavras-chave

COVID-19; SARS-CoV-2; South Korea; breakthrough; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine; viruses; zoonoses

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google